doi: 10.1097/01.hjh.0000160216.86597.ff 201
Shirin H, Aeed H, Alin A, Matas Z, Kirchner M, Brazowski E et al
The relevant analytical framework follows the ICH Q6B guidance for peptide drug substances, which covers reporting of identity, purity, content, and impurity profiles
Davis R, Thelander M, Mann GJ, Behravan G, Soucy F, Beaulieu P, Lavalle P, Grslund A, Thelander L (1994) Purification, characterization, and localization of subunit interaction area of recombinant mouse ribonucleotide reductase R1 subunit
The manufacturing process for high-discharge cells is more complex and uses higher-grade materials
We dive deeper into the implications of smaller portion sizes, pharmaceutical safety practices versus circular packaging initiatives, supply chain traceability, and more